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Follicular Dendritic Cell Sarcoma Presenting as a
Submucosal Tumor of the Stomach
Jae-Ho Han, MD; Se-Hoon Kim, MD; Sung-Hun Noh, MD; Yong-Chan Lee, MD; Ho-Guen Kim, MD; Woo-Ick Yang, MD
● Follicular dendritic cell (FDC) sarcomas, especially those
of extranodal origin, are extremely rare, and this entity
could easily be missed without a high index of suspicion.
We report a case of FDC sarcoma presenting as a submu-
cosal tumor of the stomach in a 45-year-old man. The mass
was a spindle and epithelioid mesenchymal tumor with
many individually scattered and perivascular aggregates of
lymphocytes. Immunohistochemical and ultrastructural
studies confirmed the diagnosis. Although more than 50
cases of this tumor have been documented in the English
literature, to our knowledge the presentation of FDC sar-
coma as a submucosal tumor of the stomach has never
been recorded. This case highlights the occurrence of FDC
sarcoma as a submucosal tumor of the gastrointestinal
tract. We believe that FDC sarcoma should be included in
the differential diagnosis of spindle or epithelioid cell tu-
mors of the gastrointestinal hollow viscus to prevent this
still underrecognized tumor from being overlooked.
(Arch Pathol Lab Med. 2000;124:1693–1696)
Follicular dendritic cell (FDC) sarcoma is an uncommontumor of FDC origin, although more than 50 cases
have been reported in the English literature to date.1 Fol-
licular dendritic cells are antigen-presenting cells that nor-
mally form meshworks in lymphoid follicles, and FDC
sarcomas in general recapitulate both the histologic and
ultrastructural findings and the immunophenotypic pro-
file of FDCs. This tumor affects mainly the lymph nodes,
but it also involves extranodal sites in about one third of
cases.2,3 The intra-abdominal organs are the predominant
sites of extranodal forms,2,3 but hollow viscus is rarely in-
volved and only 1 case of FDC sarcoma primarily involv-
ing the small intestine has been described to date.4 As a
result, FDC sarcoma has rarely been listed in the differ-
ential diagnosis of spindle cell neoplasms of the gastro-
intestinal tract. We report a case of FDC sarcoma pre-
senting as a submucosal mass of the stomach to highlight
its occurrence as a submucosal mass in the intra-abdom-
inal hollow viscus and to discuss its differential diagnosis.
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REPORT OF A CASE
A 45-year-old man presented with melena and dizziness of 3
weeks’ duration. Physical examination and laboratory tests were
unremarkable except for mild anemia; his serum carcinoem-
bryonic antigen level was normal. Fiber-optic gastroscopy and an
abdominal computed tomographic scan revealed a 4-cm fungat-
ing mass with a central ulceration on the antrum of the posterior
wall of the stomach. Radical subtotal gastrectomy was per-
formed, based on the pathologic diagnosis of spindle cell sarcoma
from gastroscopic biopsy specimens. The patient was well with-
out evidence of disease 10 months after surgery.
PATHOLOGIC FINDINGS
The specimen received was a resected stomach contain-
ing a 5 3 4.5-cm fungating mass. The mass was located
on the antrum of the posterior wall, and a deep, central
ulceration coated by necrotic tissue was present (Figure
1). On cut sections, the mass was well demarcated and
had a grayish-white flesh cut surface. The tumor was al-
most wholly located in the submucosa abutting the muscle
proper.
Microscopically, the well-demarcated tumor, which was
mainly located in the submucosa but had focal infiltration
into the mucosa, was composed of plump, oval to spindle-
shaped cells arranged in sheets and interlacing fascicles
(Figure 2). Although areas of short fascicles of spindle-
shaped cells that formed a vague storiform pattern were
present, most of the tumor cells had plump eosinophilic
cytoplasm with ill-defined cell borders forming a pattern-
less diffuse growth. The tumor cell nuclei were oval to
round and had a vesicular chromatin pattern (Figure 3);
some multinucleated tumor cells were also present. Focal
nuclear pleomorphism and scattered mitotic figures (av-
erage, 3 mitoses/10 high-power fields) were observed.
The tumor cells characteristically were intermingled
with many lymphocytes, and in some areas a perivascular
cuff of lymphocytes was also present (Figures 2 and 3).
Tumor metastasis was present in 1 of the resected peri-
gastric lymph nodes.
Sections from the routinely processed paraffin-embed-
ded tissue were examined immunohistochemically using
the labeled streptavidin-biotin peroxidase method (LSAB
2 kit, Dakopatts, Glostrup, Denmark). The antibodies test-
ed included CD21, CD23, CD35, CD45, CD68 (KP1), CD68
(PG-M1), CD3, L26, a-smooth muscle actin, vimentin, des-
min, S100 protein, epithelial membrane antigen, HMB-45,
CD31, and neuron-specific enolase (Dakopatts); cytokera-
tin (AE1/AE3), synaptophysin, and factor XIIIa (Bio-
Genex, San Ramon, Calif); CD34 and CNA.42 (Immuno-
tech, Westbrook, Me); and c-kit (C-19; Santa Cruz Biotech-
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Figure 1. The radical subtotal gastrectomy specimen showing the 5 3 4.5-cm fungating tumor mass with central ulceration on the posterior wall
of the antrum.
Figure 2. Low-power view of the well-demarcated submucosal tumor composed of plump ovoid cells (hematoxylin-eosin, original magnification
340).
Figure 3. Plump spindly tumor cells with vesicular nuclei forming a sheetlike growth pattern associated with sprinkling of small lymphocytes
(hematoxylin-eosin, original magnification 3200).
Figure 4. Strong cell membrane and cytoplasmic immunoreaction in the tumor cells to CD21 and CD35 cocktail (DAB chromogen with he-
matoxylin counterstain, original magnification 3200).
nology, Santa Cruz, Calif). Antigen retrieval by trypsin for
CD21, CD35, and cytokeratin, and by microwave for other
antibodies except for a-smooth muscle actin, synaptophy-
sin, S100 protein, and neuron-specific enolase were per-
formed before incubation with antibodies. An in situ hy-
bridization study for Epstein-Barr virus-encoded (EBER1)
mRNA was performed using the probe and detection sys-
tem from Novocastra (Newcastle upon Tyne, United King-
dom). Tumor cells expressed membrane and cytoplasmic
immunoreactivity for FDC markers (CNA.42, CD21,
CD23, and CD35) (Figure 4). Cytoplasmic expression of
epithelial membrane antigen, CD68 (KP1), a-smooth mus-
cle actin, vimentin, and factor XIII were also present, and
focal nuclear and cytoplasmic immunoreactivity for S100
protein was detected. Most of the lymphoid cells were T
cells expressing polyclonal CD3, with a minor population
of B cells expressing L26. No immunoreactivity was dem-
onstrated for CD45, CD3, L26, desmin, HMB-45, neuron-
specific enolase, synaptophysin, cytokeratin, CD31, CD34,
and c-kit in the tumor cells. CD68 (PG-M1) was expressed
only in reactive dendritic cells within the tumor. The nu-
clear signal for EBER1 mRNA was not detected by the in
situ hybridization method.
Ultrastructural examination of the paraffin-embedded
tissue demonstrated long and thin interdigitating cyto-
plasmic processes and desmosomal cell junctions between
adjacent cell processes (Figure 5).
COMMENT
In this report, we describe a hitherto unreported pre-
sentation of a rare tumor, which was identified as FDC
sarcoma by the results of histopathologic, immunohisto-
chemical, and ultrastructural studies. Follicular dendritic
cells, interdigitating dendritic cells, and Langerhans cells
are the major nonphagocytic antigen-presenting accessory
cells of the immune system. They reside in different com-
partments of the immune system and differ in their func-
tional, morphologic, and immunophenotypic aspects. Each
of these cells can give rise to proliferative lesions. Among
these, Langerhans cell histiocytosis is the most common
and well known, whereas FDC and interdigitating den-
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Figure 5. The long, slender, interweaving cytoplasmic processes fo-
cally connected by desmosomal cell junctions (uranyl acetate–lead cit-
rate, original magnification 342 000).
dritic cell sarcomas are relatively recently established,
rare, and underrecognized.
Although Lennert5 suggested the existence of FDC tu-
mor in 1978, the first report of FDC sarcoma was de-
scribed by Monda et al6 in 1986. They reported 4 cases of
nodal spindle cell neoplasms with features suggestive of
dendritic reticulum cell differentiation based on the ex-
pression of a dendritic reticulum cell marker (R4/23) and
the presence of long, complex cytoplasmic extensions and
numerous macula adherens–type cell junctions. The ex-
tranodal presentation of this tumor was first demonstrated
by Chan et al,7 who reported 2 cases of FDC sarcomas
arising from the palate and tonsil 8 years after the first
report of this tumor. Currently, more than 50 FDC sarco-
mas have been described in the English literature.1 The
most common location is the cervical lymph nodes, but in
about one third of cases FDC sarcoma presents as an ex-
tranodal mass. Interestingly, intra-abdominal organs (ret-
roperitoneum, mesentery, spleen, pancreas, and peripan-
creatic tissues) and the upper aerodigestive tract (tonsil,
palate, and pharynx) are the sites of predilection for this
tumor.2,3 However, mural involvement of the hollow gas-
trointestinal viscus is extremely rare, and only 1 case pri-
marily involving the small intestine and the adjacent mes-
entery has been described.4 Consequently, FDC sarcoma
is seldom listed in the differential diagnosis of spindle cell
tumors of the gastrointestinal tract.
Because FDC sarcoma occurs rarely in the hollow vis-
cus, several tumors should be excluded before diagnosis.
Follicular dendritic cell sarcoma can show diverse histo-
logic patterns, the most common of which is fascicular or
storiform proliferation of the spindle cells.2,3 Sometimes,
epithelioid cells with plump cytoplasm predominate, as
they did in our case. As in nontumorous FDCs, the cell
borders are indistinct irrespective of the cytologic features,
causing a syncytial appearance. Another important diag-
nostic clue is the intimate admixture of tumor cells and
lymphocytes, and in a few cases lymphocytes can far out-
number the tumor cells, giving a false impression of small
lymphoid cell malignancy.8 Although FDC sarcoma has
fairly characteristic histologic features, confirmation of the
cell lineage by immunohistochemical staining is manda-
tory for a definitive diagnosis. The immunophenotype and
ultrastructure of FDC sarcoma recapitulate those of FDCs,
so numerous interdigitating cytoplasmic processes joined
by desmosomes are invariably present, as in our case. The
most widely used practical FDC markers are the CD21
and CD35 antibodies. They are commercially available,
and some of antibodies work on paraffin-embedded tissue
sections, following meticulous antigen retrieval by en-
zymes. CD23 antibodies can be used as relatively specific
markers of FDC sarcoma, and they are easier to handle
than CD21 and CD35 because they work well after heat-
induced antigen retrieval. Low-affinity nerve growth fac-
tor receptor9 and CNA.4210 have been described as sensi-
tive markers for FDCs, but they lack specificity. In addi-
tion, actin, epithelial membrane antigen, CD68, S100 pro-
tein, and desmoplakin have been reported to be expressed
in some FDC sarcomas.2,3 However, these markers lack
specificity, and their use without specific FDC markers can
even lead to erroneous typing of spindle cell tumors. Pos-
itive immunostaining for factor XIIIa, as found in our case,
has not been reported previously. The antibody against
factor XIIIa labels dermal dendrocytes, and some of the
spindle cell tumors, including dermatofibroma, malignant
fibrous histiocytoma, fibrosarcoma, leiomyosarcoma, neu-
rofibroma, malignant peripheral nerve sheath tumor, and
Kaposi sarcoma, have been reported to express this mark-
er.11,12 Follicular dendritic cell sarcoma does not usually
express CD45, and no report to date has described a con-
vincing expression of cytokeratin, desmin, CD31, CD34, c-
kit, or HMB-45.2,3
Mesenchymal tumors of the gastrointestinal tract are
uncommon compared to epithelial tumors, and most are
gastrointestinal stromal tumors (GISTs) composed of un-
committed spindle cells. The tumor cells of GISTs usually
have less eosinophilic cytoplasm compared to the cells of
spindle cell tumors, which show more specific differenti-
ation, as in smooth muscle and neurogenic tumors. How-
ever, GISTs can show diverse histologic features, including
epithelioid and myxoid forms, and the distinction is not
always possible without the help of immunohistochemical
and ultrastructural studies.13,14 CD34 immunoreactivity
has been used as a useful diagnostic marker of GIST,15 but
c-kit immunoreactivity recently has been accepted as a
highly sensitive and biologically relevant marker of GIST.16
We could not make a definite histologic diagnosis on the
basis of the gastroscopic biopsy specimens and initially
considered the possibility of an unusual morphologic var-
iant of GIST in the resected specimen, until the results of
c-kit and CD34 immunostaining proved negative. The ep-
ithelioid variant of leiomyosarcoma, malignant peripheral
nerve sheath tumor, and gastrointestinal autonomic nerve
tumor were also included in the differential diagnosis;
however, the sprinkling of lymphocytes throughout the tu-
mor, coupled with the storiform or whorled growth pat-
tern of the spindle tumor cells in some areas, and the syn-
cytial appearance of the tumor cells were important in-
dications of an FDC sarcoma. Eventually, the results of our
immunohistochemical and ultrastructural studies con-
firmed the diagnosis of FDC sarcoma, and we could ex-
clude these diagnostic possibilities.
The location and morphology of our case suggested a
diagnosis of sarcomatoid carcinoma.17 Sarcomatoid carci-
noma usually presents as a fungating mass in the hollow
viscus and demonstrates a wide morphologic spectrum.
However, it can be distinguished by its tendency to have
an infiltrative margin and by the presence of more obvious
nuclear pleomorphism. In addition, areas of cytokeratin-
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positive carcinoma should be present, and immunoreac-
tivity to FDC markers (CD21, CD23, and CD35) has not
yet been reported in sarcomatoid carcinoma. Lymphocyte-
rich undifferentiated carcinoma was excluded in a similar
way.
Although malignant fibrous histiocytoma is unusual in
the stomach,18 the presence of spindle cells in a storiform
pattern and multinucleated tumor giant cells raised the
possibility of malignant fibrous histiocytoma. The lack of
marked cytologic atypia and the expression of lineage-
specific markers precluded this diagnosis.19 Malignant
melanoma could be excluded by the expression of FDC
markers and the absence of melanosomes and HMB-45
expression.
Interdigitating reticulum cell (interdigitating dendritic
cell) sarcoma is another type of neoplasm of reticular den-
dritic cell origin, and it shares some histologic, immuno-
phenotypic, and ultrastructural features with FDC sarco-
ma. Fewer cases of interdigitating dendritic cell sarcoma
have been reported than for FDC sarcoma,1 and this lesion
can also present as an extranodal mass, including in the
gastrointestinal tract.20,21 Although there is some overlap
of immunophenotypic profiles, the presence of FDC mark-
ers and the lack of CD45 expression excluded the diag-
nosis of interdigitating dendritic cell sarcoma. Sparse in-
tracytoplasmic organelles and interdigitating cytoplasmic
processes are common ultrastructural features, but inter-
digitating dendritic cell sarcoma does not show desmo-
somes.
The majority of the reported cases of FDC sarcomas
have no known etiologic or predisposing factors. Hyaline-
vascular Castleman disease sometimes demonstrates pro-
liferating and dysplastic FDCs, and a number of cases of
FDC sarcomas complicating Castleman disease have been
reported, which suggests a hyperplasia-dysplasia-neopla-
sia sequence of FDC sarcoma in some cases.2,8,22,23 Scat-
tered mucosa-associated lymphoid tissue with secondary
lymphoid follicles (probably induced by Helicobacter pylori
infection) was present in the resected stomach, but dys-
plastic FDCs were not observed in the follicles. Although
Epstein-Barr virus has been demonstrated in selected cas-
es of FDC sarcomas,2,3,23–25 it is unlikely that this virus
plays an important role as an etiologic agent, and our case
did not reveal any nuclear signal on EBER1 mRNA in situ
hybridization, which is the most specific and sensitive
method for the detection of Epstein-Barr virus.
The biological behavior of this tumor is difficult to pre-
dict, but in general it is more akin to that of an interme-
diate-grade soft tissue sarcoma than a malignant lympho-
ma.23 An intra-abdominal location was reported to be as-
sociated with a particularly aggressive course, along with
a high mitotic count ($5 mitoses/10 high-power fields),
coagulative necrosis, and significant cellular atypia.2,3,23
Our case interestingly demonstrated perigastric lymph
node metastasis, despite the early stage of the primary
tumor. The patient was doing well 10 months after cura-
tive surgery, but his clinical course is uncertain because
he has already demonstrated regional lymph node metas-
tasis.
In summary, we have described the unusual case of an
FDC sarcoma presenting as a gastric submucosal tumor
in a 45-year-old man. This case highlights the occurrence
of FDC sarcoma as a submucosal tumor of the gastroin-
testinal tract and demonstrates that FDC sarcoma should
be considered in cases of c-kit– and CD34-immunonega-
tive spindle or epithelioid cell tumors of the gastrointes-
tinal hollow viscus, particularly if lymphocytes are inti-
mately admixed intratumorally.
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